Beta Bionics, Inc. (BBNX) Cash from Financing Activities (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Cash from Financing Activities data on file, last reported at $623000.0 in Q1 2026.

• Quarterly Cash from Financing Activities fell 99.7% year-over-year to $623000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (down 98.36% YoY) and the FY2025 annual result came in at $214.9 million, up 286.36% from the prior year.
• Cash from Financing Activities eased to $623000.0 in Q1 2026 per BBNX's latest filing, from $1.1 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $211.1 million in Q1 2025, with the low at -$1.2 million in Q3 2024.
• Average Cash from Financing Activities over 3 years is $30.1 million, with a median of $623000.0 recorded in 2026.
• Year-over-year, Cash from Financing Activities jumped 3518550.0% in 2025 and slumped 99.7% in 2026.
• Beta Bionics' Cash from Financing Activities stood at $56.9 million in 2024, then sank by 98.14% to $1.1 million in 2025, then slumped by 41.23% to $623000.0 in 2026.
• Business Quant data shows BBNX's Cash from Financing Activities at $623000.0 in Q1 2026, $1.1 million in Q4 2025, and $2.7 million in Q3 2025.